BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5639734)

  • 1. The importance of the state medical journal to the pharmaceutical industry.
    Stetler CJ
    J Med Assoc Ga; 1968 Feb; 57(2):73-7. PubMed ID: 5639734
    [No Abstract]   [Full Text] [Related]  

  • 2. Title XIX, the State Medical Journal and the pharmaceutical manufacturer.
    Warner RS
    Ohio State Med J; 1968 Jun; 64(6):674-8. PubMed ID: 5656667
    [No Abstract]   [Full Text] [Related]  

  • 3. Pennsylvania Medical Society and Pennsylvania Medicine in tribute to the pharmaceutical industry.
    Pa Med; 1970 Feb; 73(2):39-100. PubMed ID: 5415141
    [No Abstract]   [Full Text] [Related]  

  • 4. Journal supplements, libraries, and the FDA.
    Caelleigh AS
    Bull Med Libr Assoc; 1993 Apr; 81(2):237-9. PubMed ID: 8472012
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical ads in journals.
    Liebman M
    Ann Intern Med; 1992 Oct; 117(7):617; author reply 618-9. PubMed ID: 1524341
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical ads in journals.
    Beary JF
    Ann Intern Med; 1992 Oct; 117(7):616; author reply 618-9. PubMed ID: 1524338
    [No Abstract]   [Full Text] [Related]  

  • 7. Journal grows suspicious of Vioxx data.
    Wadman M
    Nature; 2005 Dec; 438(7070):899. PubMed ID: 16355178
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA allows drug firms to distribute journal articles about unapproved uses.
    Tanne JH
    BMJ; 2009 Jan; 338():b187. PubMed ID: 19153126
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical advertising in the Journal.
    Pierach CA
    N Engl J Med; 1992 Dec; 327(23):1688-9. PubMed ID: 1435912
    [No Abstract]   [Full Text] [Related]  

  • 10. Annual discourse--swinging copy and sober science.
    Ingelfinger FJ
    N Engl J Med; 1969 Sep; 281(10):526-32. PubMed ID: 5800512
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859
    [No Abstract]   [Full Text] [Related]  

  • 12. The professional society circus.
    Kassirer JP
    J Public Health Policy; 2005 Dec; 26(4):400-3. PubMed ID: 16392739
    [No Abstract]   [Full Text] [Related]  

  • 13. Major medical journals will require registration of clinical trials for publication.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Oct; 15(19):1-2, 6-7. PubMed ID: 15473047
    [No Abstract]   [Full Text] [Related]  

  • 14. Courts crack down on drug marketing strategies.
    Ready T
    Nat Med; 2004 Jul; 10(7):655. PubMed ID: 15229493
    [No Abstract]   [Full Text] [Related]  

  • 15. Criteria for journal reports of suspected drug reactions.
    Jones JK
    Clin Pharm; 1982; 1(6):554-5. PubMed ID: 7185544
    [No Abstract]   [Full Text] [Related]  

  • 16. The coin needn't smell: a response to the Seidenberg thesis.
    Usdin G
    Ment Hyg; 1971 Jan; 55(1):32-4. PubMed ID: 5549643
    [No Abstract]   [Full Text] [Related]  

  • 17. The changing landscape of pharmaceutical medicine.
    Lazarus A
    Physician Exec; 2004; 30(4):40-3. PubMed ID: 15344644
    [No Abstract]   [Full Text] [Related]  

  • 18. Dispute puts a medical journal under fire.
    Meier B
    N Y Times Web; 2005 Jan; ():C1, C5. PubMed ID: 15709254
    [No Abstract]   [Full Text] [Related]  

  • 19. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of the Society for Academic Emergency Medicine.
    Biros MH;
    Acad Emerg Med; 2007 Apr; 14(4):e27-9. PubMed ID: 17322570
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the medical director in the pharmaceutical industry.
    Lyght CE
    Curr Ther Res Clin Exp; 1975 Apr; 17(4):408-17. PubMed ID: 804390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.